Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German industry wants say in reimbursement decisions:

This article was originally published in Clinica

Executive Summary

Germany's BVMed industry association says its knowledge and expertise should be used by the health ministry's reimbursement bodies when it comes to decision-making on healthcare products. In a recent position paper (see www.bvmed and go to Publikationen- Stellungnahme), the Berlin association said its practical, industry-relevant insight would be valuable to the joint federal committee (G-BA) and its executive arm, IQWiG in bringing cost-effective, innovative advanced medical technologies into circulation. BVMed director Joachim Schmitt has long campaigned for industry to be better consulted on technical medtech issues, on cost-benefit grounds and for the benefit of German patients (see Clinica No 1157, p 8).

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046696

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel